Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.

Health Diagnostics

Computing

Neuroscience

Education

Health Care

Wearables

Biotechnology

Medical Devices

Rhaeos

Anna Lisa Somera

Nikhil S.

Nikhil Saukhla

Siddharth Krishnan

James Crouthamel

Chad Webb

Bill Kabitz

John Adair

Jenna Koschnitzky

R. Chad Webb

Adam Zysk

The Advisory Group at Rhaeos provides strategic guidance and expert insights to help steer the development and commercialization of the company's innovative FlowSense technology. Comprised of seasoned professionals and an advocate/investor, this team advises on clinical, regulatory, and market positioning to ensure successful product adoption and impact in the medical device industry.

Advisory Group

Leadership Team

Product Development Team

Advisory Group

About

Team members

Other teams at Rhaeos

Leadership Team

Product Development Team